When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works.

Sam Altman shares more details on how ChatGPT will be monetized

The OpenAI logo

Sam Altman, the CEO of OpenAI which developed ChatGPT, has said that the company is focused on developing a platform that sells APIs to businesses to develop artificial intelligence apps like ChatGPT. According to Reuters, Altman said that his company is already working with enterprise customers to train models in specific domains which is helping to reduce responses that are incorrect.

Some companies have already started working with OpenAI, one is the soda company Coca-Cola which is using OpenAI’s ChatGPT and DALL-E technologies to create personalized ad copy, images, and messaging. By developing APIs for enterprise customers, OpenAI stands to make a lot of money.

Away from enterprise, OpenAI wants to give users more control over how ChatGPT works. This customization could help to soothe people’s concerns about biases that ChatGPT has. In the near future, Altman expects that people will get other applications powered by AI on their phones, including AI doctors and lawyers. He did admit though that the AI won’t be 100% accurate so end users still need to exercise some caution.

Lots of tech companies have sat up and taken notice of the launch of ChatGPT and begun implementing similar technologies in their products. It’ll definitely be interesting to see what else emerges in the coming months based on these technologies – those AI doctors and lawyers could prove to be very useful.

Source: Reuters

Report a problem with article
Resident Evil 4 remake announcement keyart
Next Article

The Resident Evil 4 Chainsaw Demo is available now ahead of the remake's March 24 release

An image with a colorful Windows 11 logo and dimmed background
Previous Article

Microsoft working to add dedicated, much-improved USB4 Settings page in Windows 11 22H2

Join the conversation!

Login or Sign Up to read and post a comment.

1 Comment - Add comment